Sintx Technologies: A Buy Rating With Promising Growth and Market Expansion Opportunities
SINTX Techs Analyst Ratings
Ascendiant Remains a Buy on Sintx Technologies (SINT)
Maxim Group Keeps Their Buy Rating on Sintx Technologies (SINT)
Maxim Group Sticks to Its Buy Rating for Sintx Technologies (SINT)
Sintx Technologies (SINT) Gets a Buy From Ascendiant
Maxim Adjusts Price Target on Sintx Technologies to $6 From $7, Maintains Buy Rating
Maxim Group Maintains Buy on SINTX Technologies, Lowers Price Target to $6
SINTX Technologies Analyst Ratings
Maxim Group Maintains Buy on SINTX Technologies, Lowers Price Target to $7
Maxim Adjusts Price Target on Sintx Technologies to $22 From $35, Maintains Buy Rating
SINTX Technologies Analyst Ratings
Maxim Group Maintains Buy on SINTX Technologies, Lowers Price Target to $22
Analysts Offer Insights on Healthcare Companies: Sintx Technologies (SINT), Motus Gi Holdings (MOTS) and Valneva (VALN)
Maxim Group Sticks to Its Buy Rating for Sintx Technologies (SINT)
No Data